Keri Forsythe-Stephens

2 months ago | axisimagingnews.com | Keri Forsythe-Stephens |Imaging Research

Summary: A study in Academic Emergency Medicine found significant variability in imaging for pediatric appendicitis in Michigan, with large pediatric centers favoring ultrasound and MRI over CT scans to reduce radiation while ensuring timely diagnosis. Imaging practices for pediatric appendicitis vary widely across Michigan hospitals, with large pediatric centers favoring ultrasound and MRI over CT scans to minimize radiation exposure.

2 months ago | axisimagingnews.com | Keri Forsythe-Stephens

Summary: SNMMI has launched the pilot phase of the Thyroid Cancer Registry within its Radiopharmaceutical Therapy Registry platform to collect real-world data on radiopharmaceutical therapies, support research, and improve patient outcomes, with a full launch expected by the end of 2025. SNMMI has launched the pilot phase of the Thyroid Cancer Registry as part of its Radiopharmaceutical Therapy Registry (RaPTR) platform to collect real-world data on radiopharmaceutical therapies.

2 months ago | axisimagingnews.com | Keri Forsythe-Stephens |Imaging Research

Summary: Two new PET radiotracers demonstrated superior binding and selectivity compared to the FDA-approved radiotracer for detecting tau tangles, aiding Alzheimer’s diagnosis, staging, and clinical trial outcomes. Two next-generation PET radiotracers, 18F-MK6240 and 18F-PI2620, demonstrated higher binding and selectivity for tau tangles in Alzheimer’s disease brain tissue compared to the FDA-approved 18F-Flortaucipir.

2 months ago | axisimagingnews.com | Keri Forsythe-Stephens |Imaging Research

Summary: MRI scans revealed that adults with sickle cell disease have brains that appear 14 years older than their actual age, highlighting how chronic oxygen deprivation and socioeconomic factors contribute to premature brain aging and cognitive challenges.

2 months ago | axisimagingnews.com | Keri Forsythe-Stephens

Summary: SNMMI and the European Association of Nuclear Medicine have released new guidelines for fibroblast activation protein PET imaging, detailing its cancer and disease applications, offering evidence-based recommendations, and emphasizing the need for further clinical trials.